Generation
|
Antibiotic
|
Route
|
Notes
|
First
|
cefadroxil
|
PO
|
|
cefazolin
|
IV
|
|
cephacetrile
|
|
|
cephalexin
|
PO
|
|
cephaloridine
|
|
|
cephalothin
|
IV
|
previously used to predict cefazolin susceptibilty
|
cephapirin
|
|
|
cephradine
|
PO/IV
|
|
Second
|
cefaclor
|
PO
|
|
cefamandole
|
|
|
cefonicid
|
|
|
ceforanide
|
|
|
cefotiam
|
PO/IV
|
|
cefprozil
|
PO
|
sometimes thought of as a third-generation
|
cefuroxime
|
PO/IV
|
|
cefuzonam
|
|
severe skin reactions
|
loracarbef
|
PO
|
|
Cephamycins
|
cefmetazole
|
|
|
cefotetan
|
|
|
cefoxitin
|
|
|
flomoxef
|
|
|
Third
|
cefdinir
|
PO
|
|
cefditoren
|
PO
|
|
cefixime
|
PO
|
|
cefoperazone
|
IV
|
coformulated with sulbactam
|
cefotaxime
|
IV
|
very similar to ceftriaxone
|
cefpiramide
|
|
sometimes described as a fourth-generation; may be active against Pseudomonas aeruginosa
|
cefpodoxime
|
PO
|
|
cefsulodin
|
PO
|
sometimes described as a fourth-generation; may be active against Pseudomonas aeruginosa
|
ceftazidime
|
IV
|
active against Pseudomonas aeruginosa; may be coformulated with avibactam
|
ceftibuten
|
PO
|
|
ceftizoxime
|
|
|
ceftriaxone
|
IV
|
|
Fourth
|
cefepime
|
IV
|
active against Pseudomonas aeruginosa and AmpC producers
|
cefpirome
|
|
|
Fifth
|
ceftaroline
|
IV
|
active against MRSA; may be coformulated with avibactam
|
ceftobiprole
|
IV
|
active against MRSA
|
ceftolozane
|
IV
|
coformulated with tazobactam; active against Pseudomonas aeruginosa and ESBL producers
|
Siderophore
|
cefiderocol
|
IV
|